First-pass effect: significance of the intestine for absorption and metabolism

Drug and Chemical Toxicology
M M Doherty, K S Pang

Abstract

The occurrence of low systemic availability due to significant metabolism or poor absorption of orally administered drugs has been well recognized. Three rate controlling factors affecting the oral absorption: unstirred water layer, membrane limitation, or flow limitation, have been identified. These are much affected by the physicochemical properties of the drug: pKA, water/lipid solubility, structural mimicry to endogenous substrates for transport proteins, and the physiology of the GI tract. Drug metabolizing enzymes are found to be present in the intestine, albeit the content is lower than that found in liver. The presence of pre-absorptive versus post-absorptive intestinal metabolism is presently discussed in experimental sets of data with luminal and systemic administration of the drugs in the vascularly perfused rat small intestine preparation. The effect of the anterior anatomical placement of the intestine and its contribution to metabolism, in relation to that for the liver, has been examined in our laboratory by the perfused intestine-liver preparation. The effect of concentration and flow have been studied and general principles governing drug absorption and metabolism in the intestine and the subsequent effects on ...Continue Reading

References

Apr 1, 1976·Journal of Pharmaceutical Sciences·B G Boggiano, M Gleeson
Jan 1, 1976·Clinical Pharmacokinetics·W S Nimmo
Aug 1, 1976·Journal of Pharmaceutical Sciences·J M BlahaS L Hem
Jan 1, 1992·Critical Reviews in Oncology/hematology·L J GoldsteinM M Gottesman
Jul 12, 1991·Biochimica Et Biophysica Acta·M C LinF A Wilson
Sep 9, 1991·Biochemical and Biophysical Research Communications·Y Z GongF A Wilson
Aug 1, 1991·Pharmaceutical Research·P J SinkoG L Amidon
Jan 1, 1990·Pharmacology & Therapeutics·K F IlettR F Minchin
Dec 1, 1990·Clinical Pharmacology and Therapeutics·J X MazoitA Roche
Dec 1, 1988·Journal of Pharmaceutical Sciences·M Hu, G L Amidon
May 1, 1988·Journal of Pharmacobio-dynamics·S K PodderJ Shibasaki
Mar 1, 1988·British Journal of Clinical Pharmacology·S K GuptaM Rowland
Jun 1, 1987·British Journal of Clinical Pharmacology·S M RogersM L Orme
Feb 1, 1986·The American Journal of Clinical Nutrition·F K GhishanH L Greene
Feb 1, 1986·Journal of Pharmaceutical Sciences·J B Dressman, D Fleisher
Feb 1, 1986·Journal of Pharmaceutical Sciences·D A Johnson, G L Amidon
Jul 1, 1971·British Journal of Pharmacology·S H CurryG P Mould
May 1, 1969·Clinica Chimica Acta; International Journal of Clinical Chemistry·D W Piper, B H Fenton
Aug 1, 1984·Journal of Pharmacokinetics and Biopharmaceutics·M W LoT N Tozer
Dec 1, 1980·Journal of Pharmaceutical Sciences·G L AmidonR L Elliott
Apr 1, 1980·Japanese Journal of Pharmacology·K SakaiR Niki
Jul 1, 1995·Clinical Pharmacology and Therapeutics·D Y GomezL Z Benet
May 1, 1995·Clinical Pharmacology and Therapeutics·M P DucharmeD J Edwards
Jan 1, 1995·Cancer Chemotherapy and Pharmacology·B L Leu, J D Huang
Feb 1, 1994·Clinical Pharmacokinetics·D R Krishna, U Klotz

❮ Previous
Next ❯

Citations

Feb 3, 2007·Expert Opinion on Drug Metabolism & Toxicology·Joseph K Ritter
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Hong Wan, Johan Ulander
Jul 23, 2009·Journal of Pharmacological and Toxicological Methods·Luka PeternelManica Cerne
Apr 1, 2008·Pharmacology & Therapeutics·John C Lipscomb, Torka S Poet
Jul 25, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hirokazu UyamaNorio Hayashi
Mar 19, 2016·Drug Metabolism Reviews·Mohd Yaseen MalikJawahar Lal
Feb 1, 2006·Environmental Toxicology and Pharmacology·Richard A Fearn, Barry H Hirst
Feb 11, 2015·Clinical Pharmacokinetics·Kamla Pathak, Smita Raghuvanshi
Apr 30, 2002·Clinical Pharmacokinetics·Margaret M Doherty, William N Charman
Aug 7, 2002·Clinical Pharmacokinetics·Michael S RobertsMichael Weiss
Jun 1, 2004·Pharmacological Reviews·Allan J McLean, David G Le Couteur
Apr 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Camille P GranvilFrank J Gonzalez
Nov 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·K Sandy Pang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Biochemical and Biophysical Research Communications
Maziya Ibrahim, Sharmila Anishetty
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
E OvervikJ A Gustafsson
© 2021 Meta ULC. All rights reserved